Eisai first quarter results story – correction
This article was originally published in Scrip
Executive Summary
The title of the August 1st Scrip Online story on Eisai's first quarter results should have read: "MGI boost for Eisai, but rabeprazole languishes", not "MGI boost for Eisai but lansoprazole languishes". Rabeprazole should also have been substituted for lansoprazole in the fourth paragraph of the story, which referred to the development of over-the-counter versions of the product.